Related Experiment Videos
Current rheumatological uses of intravenous immunoglobulin
British Journal of Rheumatology
|November 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A case of chronic melioidosis responding to tetracycline therapy.
The Medical journal of Malaysia·2022
Asthma and airways collapse in two heritable disorders of connective tissue.
Annals of the rheumatic diseases·2007
Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic.
Pediatric pulmonology·2005
Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.
British journal of rheumatology·1999
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.
British journal of rheumatology·1999
Circulating interleukin-16 in systemic lupus erythematosus.
British journal of rheumatology·1999
Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
British journal of rheumatology·1999
Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.
British journal of rheumatology·1999
A study of the frequency of pericardial and pleural effusions in scleroderma.
British journal of rheumatology·1999
Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.
Microbiology spectrum·2026
IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026
Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cells.
Molecular therapy. Advances·2026
CAR design equips diverse immune cells with unique antigen-specific activation identities.
Molecular therapy. Oncology·2026